Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cholecystitis
ADR ID BADD_A00901
ADR Hierarchy
09      Hepatobiliary disorders
09.03      Gallbladder disorders
09.03.01      Cholecystitis and cholelithiasis
09.03.01.001      Cholecystitis
Description A disorder characterized by inflammation involving the gallbladder. It may be associated with the presence of gallstones. [CTCAE] Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. | Presence of pus in the GALLBLADDER. [MeSH]
MedDRA Code 10008612
MeSH ID D002764; D042101
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acalculous cholecystitis | Calculus of gallbladder with other cholecystitis | Calculus of gallbladder with other cholecystitis, with obstruction | Calculus of gallbladder with other cholecystitis, without mention of obstruction | Cholecystitis | Cholecystitis (alone) | Cholecystitis NOS | Cholecystitis, other | Gallbladder inflammation | Inflammation gallbladder | Other cholecystitis | Calculous cholecystitis | Gallbladder Inflammation | Inflammation, Gallbladder | Empyema, Gallbladder | Gallbladder Empyema | Empyema, Gall Bladder | Gall Bladder Empyema
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01197Iron0.000453%
BADD_D01201Isavuconazonium sulfate--
BADD_D01211Isosorbide mononitrate--
BADD_D01244Lanreotide acetate--
BADD_D01245Lansoprazole0.000149%
BADD_D01247Lanthanum carbonate0.001239%
BADD_D01250Lasofoxifene--
BADD_D01252Leflunomide0.000643%
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib0.002507%
BADD_D01275Levofloxacin--
BADD_D01285Levothyroxine0.000005%
BADD_D01318Lorazepam0.000092%
BADD_D01336Macitentan0.000361%
BADD_D01397Mesalamine--
BADD_D01418Methotrexate--
BADD_D01449Metronidazole0.000053%
BADD_D01470Minocycline0.000118%
BADD_D01476Mirtazapine--
BADD_D01499Morphine sulfate--
BADD_D01507Mycophenolate mofetil--
BADD_D01533Naproxen--
BADD_D01567Nilotinib0.000895%
BADD_D01592Obeticholic acid0.001564%
BADD_D01595Octreotide acetate--
BADD_D01602Olmesartan0.001521%
BADD_D01614Omeprazole0.000007%
BADD_D01624Orlistat--
BADD_D01629Osimertinib0.000224%
BADD_D01633Oxaliplatin0.000448%
The 4th Page    First    Pre   4 5 6 7    Next   Last    Total 7 Pages